【レポートの概要（一部）】
1. Report Overview
1.1 The Molecular Diagnostics Market Overview
1.2 Molecular Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About visiongain
2. Introduction to Molecular Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 The EC (European Commission) Classification
2.2.3 IVD Classification in Australia
2.3 IVD Submarkets
2.3.1 Clinical Chemistry
2.3.2 Immunochemistry
2.3.3 Point-of-care Testing (Including Self-Monitoring Blood Glucose Tests)
2.3.4 Molecular Diagnostics
2.3.4.1 Infectious Disease Testing
2.3.4.2 Oncology Testing
2.3.4.3 Blood Screening
2.3.4.4 Genetic Testing
2.3.4.5 Tissue Typing (HLA Testing)
2.3.5 Clinical Microbiology
2.3.6 Haematology/ Haemostasis
2.4 Regulation of the IVD and MDx Market
2.4.1 FDA and CLIA Regulation of IVD and MDx Tests
2.4.2 Regulation of IVD/MDx Tests in the EU: The EC (European Commission) Classification
2.4.3 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.3.1 Challenges in Regulations of MDx Tests
2.5 Device Excise Tax: A Threat to the Diagnostics Manufacturers
3. The Molecular Diagnostics Segment within the In Vitro Diagnostics Market, 2015-2025
3.1 Molecular Diagnostics in the IVD Market, 2014
3.2 Sales Forecast for the Global IVD Market 2015-2025
3.3 Molecular Diagnostics Gaining A Greater Share of the IVD Market
4. The Molecular Diagnostics Market by Sectors, 2015-2025
4.1 The Molecular Diagnostic Market by Sectors, 2014
4.2 The Molecular Diagnostic Market by Sectors 2015-2025
4.2.1 Market Shares of the Molecular Diagnostics Sectors 2015-2025
4.3 The Infectious Disease Testing Market 2015-2025
4.3.1 Breakdown of the MDx Infectious Disease Testing Market by Disease, 2014
4.3.1.1 CT/NG
4.3.1.2 HPV Testing
4.3.1.3 HIV
4.3.1.4 Healthcare Associated Infections (HAI)
4.3.1.5 Hepatitis C (HCV)
4.3.1.6 Respiratory Infections
4.4 The Oncology Testing Market, 2015-2025
4.4.1 Targeted Therapies: A Major Driver of the Oncology Testing Market
4.4.2 Molecular Diagnostics: Currently Concentrated on a Few Cancer Indications
4.4.2.1 Breast Cancer
4.4.2.2 Prostate Cancer
4.4.2.2.1 Prostate Cancer Pipeline Biomarkers
4.4.2.2.1.1 TMPRSS2-ERG (OriGene)
4.4.2.2.1.2 PTEN
4.4.2.3 Colorectal Cancer
4.5 The Blood Screening Market 2015-2025
4.5.1 Grifols’ Acquisition of Novartis’s Blood Screening Unit
4.5.2 Leading Blood Screening Test Products
4.5.2.1 Cobas s 201 System (Roche Molecular)
4.5.2.2 Procleix Assays (Grifols)
4.6 The Genetic Testing Market 2015-2025
4.6.1 Genetic Testing by Clinical Impact Area
4.6.2 Genetic Testing: Potential beyond Oncology
4.6.3 Cystic Fibrosis
4.6.4 Factor V Leiden and Factor II Thrombophilia
4.6.5 Inflammatory Diseases
4.6.5.1 Alzheimer’s Disease (AD)
4.6.5.2 Rheumatoid Arthritis
4.6.5.2.1 Vectra®DA (Crescendo Bioscience)
4.6.5.2.2 Quest Diagnostics: Biomarker Study
4.6.5.3 Rare Diseases
4.7 The Tissue Typing (HLA Typing) Market 2015-2025
4.7.1 Tissue Typing: Next-Generation Sequencing
5. The Leading Molecular Diagnostics National Markets, 2015-2025
5.1 Regional Breakdown of the Global MDx Market, 2014
5.2 The Global MDx Market Forecast, 2015-2025
5.3 The Regional Market Shares of the MDx Market, 2014, 2019 and 2025
5.4 The US MDx Market 2014
5.4.1 The US MDx Market Forecast 2015-2025
5.4.1.1 United States: Diagnostic Reimbursement
5.5 The European MDx Markets Forecast 2015-2025
5.5.1 Changes in the Shares of the Leading European Markets, 2014, 2019 and 2025
5.5.2 Shares of the Major European Markets in a Global Context
5.5.3 The German MDx Market Forecast 2015-2025
5.5.3The French MDx Market Forecast 2015-2025
5.5.4 The Italian MDx Market Forecast 2015-2025
5.5.5 The Spanish MDx Market Forecast 2015-2025
5.5.6 The UK MDx Market Forecast 2015-2025
5.5.7 The Other European MDx Markets Forecast 2015-2025
5.6 The Japanese MDx Market Forecast 2015-2025
5.7 The Chinese MDx Market Forecast 2015-2025
5.7.1 China: Increasing Cancer Burden
5.8 The Brazilian MDx Market Forecast 2015-2025
5.9 The Russian MDx Market Forecast 2015-2025
5.10 The Indian MDx Market Forecast 2015-2025
5.10.1 India: Expansion of Healthcare Provisions
5.11 The South Korean MDx Market Forecast 2015-2025
5.12 The Mexican MDx Market Forecast 2015-2025
5.13 The Rest of the World Market Forecast 2015-2025
6. The Leading Companies in the Molecular Diagnostics Market, 2015
6.1 Roche Diagnostics
6.1.1 Roche: Global Presence
6.1.2 Roche Diagnostics, 2015-2025
6.1.3 Roche Diagnostics Business Performance within the IVD Market, 2014
6.1.3.1 Molecular Diagnostics Sales Performance, 2014
6.1.3.2 Molecular Diagnostic Sales by Region, 2014
6.1.4 Roche Diagnostics: MDx Product Launches and Indication Expansion, 2015
6.1.4.1 Roche Diagnostics: Product Launch Plans, 2015
6.1.5 Roche: Major M&A Activity and Strategic Partnerships Strengthen Position as Market Leader
6.1.5.1 Genia Acquisition to Strengthen DNA Sequencing Capabilities
6.1.5.2 IQuum Acquisition Allows Movement into POC MDx Market
6.1.5.3 Seragon Acquisition Strengthens Leading Position in Oncology
6.1.5.4 Santaris Acquisition Enchances Roche’s Position in RNA-Targeted Drugs Market
6.1.5.5 Bina Acquisition Brings Big Data Solution to Support NGS Development
6.1.5.6 Dutalys Acquisition Enhances Roche’s mAB Portfolio
6.1.5.7 Ariosa Acquisition Adds NIPT to MDx Portfolio
6.1.5.8 Foundation Medicine Deal Enhances Personalised Medicine Capabilities for Oncology
6.1.5.9 Signature and CAPP Acquisitions Strengthen Circulating DNA Testing Abilities
6.1.5.10 GENEWEAVE and Kapa Acquisitions Help Cement Roche’s Position as the MDx Market Leader
6.2 Qiagen NV
6.2.1 Sales and Recent Performance Analysis, 2014
6.2.2 Qiagen Sales by Region, 2014
6.2.3 Qiagen Sales by Segment, 2014
6.2.4 Qiagen: Molecular Diagnostics
6.2.5 Molecular Diagnostics: Product Expansion
6.2.5.1 QIASymphony
6.2.5.2 QuantiFERON-TB Gold: Expansion into Asia
6.2.5.3 Personalised Healthcare: Collaborative Efforts
6.2.5.4 Qiagen’s Software Company Acquisitions Cement Leadership in Bioinformatics
6.3 Hologic
6.3.1 Hologic Recent Sales Performance by Business Segment, 2014
6.3.2 Hologic Molecular Diagnostics: Product Portfolio
6.4 Becton, Dickinson and Company
6.4.1 Sales and Financial Performance, 2014
6.4.2 Sales and Financial Performance by Region, 2014
6.4.3 Becton, Dickinson and Company Diagnostics Sales and Financial Performance, 2013-2014
6.4.4 BD Diagnostics: Product Portfolio
6.4.5 BD Diagnostics: Mergers and Acquisitions
6.5 bioMérieux
6.5.1 Sales and Recent Performance Analysis, 2010-2014
6.5.2 Sales by Region, 2014
6.5.3 Sales by Technology, 2014
6.5.4 Molecular Diagnostics: Product Portfolio
6.5.5 Companion Diagnostics: Collaborations with GSK and Novartis
6.5.6 Mergers, Acquisitions and Collaborations
6.5.7 bioTheranostics: Subsidiary for Oncology Diagnostics
6.6 Cepheid
6.6.1 Sales and Recent Performance Analysis, 2010-2014
6.6.2 Sales by Industry Segment, 2013-2014
6.6.3 Sales by Region, 2012-2014
6.6.4 Cepheid: Product Line
6.6.5 Cepheid: Business strategy
6.7 Agilent Technologies
6.7.1 Sales and Recent Performance Analysis, 2014
6.7.2 Sales Performance by Business Segment, 2014
6.7.3 Agilent Technologies: Strong Player in Target Enrichment for Next-Generation Sequencing
7. Qualitative Analysis of the MDx Market, 2015-2025
7.1 MDx Market: Drivers and Restraints
7.2 SWOT Analysis of the MDx Market, 2015-2025
7.2.1 Strengths
7.2.1.1 Patient Demographics
7.2.1.2 Increased Awareness
7.2.1.3 High Growth in Oncology Molecular Diagnostics
7.2.1.4 Increasing Laboratory Test Menus
7.2.1.5 Personalised Medicine: Optimising Treatment Outcomes
7.2.2 Weaknesses
7.2.2.1 Lack of Clear Regulatory Guidelines for Molecular Diagnostics
7.2.2.2 Reimbursement Challenges for Molecular Diagnostic Companies
7.2.2.3 Consolidation of Healthcare Systems Increases Pricing Pressure
7.2.2.4 MDx: An Expensive, but Undervalued Diagnostic Tool
7.2.3 Opportunities
7.2.3.1 Next-Generation Sequencing
7.2.3.2 Emerging Markets
7.2.3.3 The Emergence of New Microorganisms
7.2.4 Threats
7.2.4.1 US Medical Device Excise Tax
7.2.4.2 Gene Patents: Controversial Ruling
7.3 Porter’s Five Forces Analysis of the MDx Market
7.3.1 Rivalry among Competitors [High]
7.3.2 Threat of New Entrants [Medium]
7.3.3 Power of Suppliers [Medium]
7.3.4 Power of Buyers [High]
7.3.5 Threat of Substitutes [High]
8. Research Interview
8.1 Kai te Kaat, Vice President, Global Product Management Life Sciences, Head of NGS Program, QIAGEN NV
8.1.1 QIAGEN: Pioneers in NGS Technology
8.1.2 The Future of NGS Outside Oncology
8.1.3 QIAGEN: Leading Progress in Bioinformatics
8.1.4 Regional Demand for NGS and NGS in the Wider Diagnostics Market
9. Conclusion
9.1 The Molecular Diagnostics Market: Growing Market Share
9.2 Molecular Diagnostics: Oncology Testing Market Growth
9.3 Commercial Drivers of the Molecular Diagnostics Market
9.4 Commercial Restraints of the Molecular Diagnostics Market
9.5 Emerging Markets
9.6 Concluding Remarks
10. Glossary
【レポート販売概要】
■ タイトル：分子診断（MDx）の世界市場：感染症検査、腫瘍検査、血液検査、遺伝子検査、組織適合検査（HLA）■ 英文：The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies
■ 発行日：2015年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN5102608
■ 調査対象地域：グローバル
- チューブ包装パッケージの世界市場：積層チューブ、アルミニウムチューブ、プラスチックチューブThe tube packaging market includes all the types of tubes such as squeeze tubes, twist tubes, and other tubes. The tube packaging market has varied applications, such as cosmetics & oral care, food & beverages, pharmaceuticals, consumer goods, and others. Tubes possess properties such as excellent barrier properties, convenient packaging, which fuel the growth of the tube packaging market. The mar …
- EQT Corporation：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012EQT Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary EQT Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
- 医療レポート：Acne-疫学予測（～2022）EpiCast Report: Acne - Epidemiology Forecast to 2022 Summary Acne vulgaris (acne) is an inflammatory skin disease that affects nearly all adolescents and adults at some point in their lives. The clinical presentation of acne ranges from a mild comedonal form to severe inflammatory cystic acne of the face, chest, and back. Globally, acne has a lifetime prevalence of over 90% in people of all ages, …
- SIPトランキングの世界市場2017-2021About Session Initiation Protocol TrunkingSession Initiation Protocol (SIP) trunking is an Internet-based service that permits Voice over Internet Protocol (VoIP) users to stay connected in local and long-distance calls to and from endpoints in the traditional phone network. Technavio’s analysts forecast the global session initiation protocol trunking market to grow at a CAGR of 18.23% during the …
- 粒子線治療の世界市場予測（～2023年）“The particle therapy market is projected to grow at a CAGR of 9.3% during the forecast period”The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. The growth of this market is largely driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, i …
- 3D金属印刷の世界市場分析：製品別（チタン、ニッケル、スチール、アルミニウム）、用途別（航空宇宙・防衛、自動車、医療･歯科）、形状別（粉末、フィラメント）、地域別、国別、セグメント予測The global 3D metal printing market is expected to reach USD 2.86 billion by 2025, according to a new report by Grand View Research, Inc. Metals are the fastest growing 3D printing materials worldwide on account of high application scope coupled with increasing demand from the medical and dental application.The market has witnessed advancements, both in terms of technologies and materials, in orde …
- eコマース及びインターネットビジネス年鑑2015PLUNKETT'S E-COMMERCE & INTERNET BUSINESS ALMANAC 2015 Key findings: • Plunkett Research lists top 450 companies in E-Commerce & Internet and names top trends changing the industry for the mid term. Key Features: • Industry trends analysis, market data and competitive intelligence • Market forecasts and Industry Statistics • Industry Associations and Professional Societies List • In-Depth Profiles …
- グリーン及びバイオポリオールの世界市場予測（～2021年）：ポリエーテルポリオール、ポリエステルポリオールThe global green and bio polyols market is projected to reach USD 4.71 Billion by 2021, at a CAGR of 9.5%. It is projected to reach 1.74 Million tons by 2021 at a CAGR of 6.9% from 2016 to 2021 by volume. The eco-friendly and sustainable nature of bio polyols, consistent supply of bio-based feedstock and crude oil price fluctuations, are the key factors driving the global green and bio polyols mar …
- Nebilet (Chronic Heart Failure)：市場予測と分析（～2022）Nebilet (Chronic Heart Failure) - Forecast and Market Analysis to 2022 Summary The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose market exclusivity during the next few years. GlobalData predicts that the major global barriers that will play a crucial role in narrowing the global growth of the CH …
- 世界のタイヤ市場動向（2012-2016）TechNavio's analysts forecast the Global Tire market to grow at a CAGR of 6.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for radial tires. The Global Tire market has also been witnessing an increase in factory automation. However, the increasing cost of raw materials could pose a challenge to the growth of this market. Tec …
- 通信向けクラウド式課金サービスの世界市場2015-2019Technavio market research analyst's estimate, telecom cloud billing services reached a market size of USD 2.3 billion in 2014. The market is dominated by prepaid subscribers with close to 79% of GSM subscribers using these services. Most telecom operators cater to the requirements of this market. Currently, many telecom service providers are adopting a customer-centric business model to increase t …
- リニアアクチュエーターの世界市場2018-202299 pages, November 2018 About this market The advent of Industry 4.0 and IoT have resulted in increasing demand for IoT enabled smart linear actuators. Functionalities such as rotary encoders, potentiometers, network switches, and controllers are being integrated into these smart actuators. Smart actuators are also being incorporated with various functions such as position feedback, switching, and …
- ホームアクセサリーの日本市場：PC、カメラ、ビデオカメラ、ビデオゲーム、レコーダーHome accessories are electronic (analog or digital) equipment intended for everyday use, in homes. Home accessories can be categorized into small appliance or brown goods consumer electronics. These are generally equipped with special connections such as electrical or an inbuilt battery that helps in mobility of the appliances around the house. Small appliances are semi-portable or portable machin …
- 油圧シリンダの世界市場予測（～2023年）：単動シリンダ、複動シリンダThe hydraulic cylinder market is expected to be valued at USD 13.64 Billion in 2017 and is projected to reach USD 19.30 Billion by 2023, at a CAGR of 5.95% between 2017 and 2023. The key factor driving the growth of the hydraulic cylinder market is their rising demand in the construction industry and mining process equipment. Increasing demand for lifting equipment in the shipping industry and for …
- 商用アビオニクス装置の世界市場：飛行管理システム、航法システム、通信・監視システム、HMS、電気・非常システムAvionics play a vital role in an aircraft to transmit data for purposes, such as communication, monitoring, and navigation. Avionics systems are those electronic systems that are responsible for carrying out individual functions for aircraft operations. They include all systems fitted in the cockpit of the aircraft, such as control, navigation, monitoring, communication, weather, and anti-collisio …
